Omada Health (OMDA) closed at $18.06 on Oct 19, 2026, up 2.4% on the day. The stock is down 11.6% over the past month, down 21.4% over three months, up 14.4% year to date and down 27.6% over the past year. It trades 32.9% below its 52-week high of $26.92 and 75.7% above its 52-week low of $10.28. The close sits below its 50-day moving average ($21.63) and above its 200-day moving average ($17.53).
Over its last 5 reports the stock moved an average of 8.7% on the first trading day after earnings, beating the options-implied move in 2 of 4.
Omada Grew 43% in Q2, Yet Its Guidance Leaves Only 19% for H2
Omada beat expectations in Q2, but its guidance implies second-half growth roughly halves; worth following long term, while short-term buyers should wait for small-cap money to return.
Oct 16, 2026
Over the last 5 reports, OMDA moved an average of 8.7% on the first trading day after earnings. The move beat the options-implied move in 2 of 4 reports.
Yes — the Oct 19, 2026 close of $18.06 is 3.0% above the 200-day average of $17.53.
OMDA closed 32.9% below its 52-week high of $26.92.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
